Metaphore Biotechnologies
Robert W. Link is a Scientist II in Computational Biology at Metaphore Biotechnologies since August 2022. Previously, Robert served as a Postdoctoral Fellow at Drexel University College of Medicine, where notable work included the development of HIV-Quasipore, a deep learning-based HIV-1-specific basecaller suite. As a Graduate Research Assistant at Drexel University School of Biomedical Engineering, Science and Health Systems, Robert focused on sequence-based deep learning models to explore the impact of HIV-1 Tat variation on miRNA binding and off-target effects for CRISPR-Cas9 gRNA design. Robert's academic background includes a PhD in Computational Biology from Drexel University and a Bachelor of Science in Biochemistry from Juniata College, complemented by a minor in Philosophy.
This person is not in any offices
Metaphore Biotechnologies
Metaphore Biotechnologies is harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. The company’s MIMiC™ platform is a computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized. Metaphore is focused on making previously intractable drug targets accessible and unlocking breakthroughs that outperform today’s drugs for maximum patient impact. Metaphore was founded in 2021 in Flagship Labs, a unit of Flagship Pioneering.